AAAAAA

   
Results: 1-20 |
Results: 20
PROSTATE-CANCER AND SUPPLEMENTATION WITH ALPHA-TOCOPHEROL AND BETA-CAROTENE - INCIDENCE AND MORTALITY IN A CONTROLLED TRIAL
Authors: HEINONEN OP ALBANES D VIRTAMO J TAYLOR PR HUTTUNEN JK HARTMAN AM HAAPAKOSKI J MALILA N RAUTALAHTI M RIPATTI S MAENPAA H TEERENHOVI L KOSS L VIROLAINEN M EDWARDS BK
Citation: Op. Heinonen et al., PROSTATE-CANCER AND SUPPLEMENTATION WITH ALPHA-TOCOPHEROL AND BETA-CAROTENE - INCIDENCE AND MORTALITY IN A CONTROLLED TRIAL, Journal of the National Cancer Institute, 90(6), 1998, pp. 440-446
GAIN OF 3Q AND DELETION OF 11Q22 ARE FREQUENT ABERRATIONS IN MANTLE CELL LYMPHOMA
Authors: MONNI O OINONEN R ELONEN E FRANSSILA K TEERENHOVI L JOENSUU H KNUUTILA S
Citation: O. Monni et al., GAIN OF 3Q AND DELETION OF 11Q22 ARE FREQUENT ABERRATIONS IN MANTLE CELL LYMPHOMA, Genes, chromosomes & cancer, 21(4), 1998, pp. 298-307
MANTLE CELL LYMPHOMA - CLINICAL-FEATURES, TREATMENT AND PROGNOSIS OF 94 PATIENTS
Authors: OINONEN R FRANSSILA K TEERENHOVI L LAPPALAINEN K ELONEN E
Citation: R. Oinonen et al., MANTLE CELL LYMPHOMA - CLINICAL-FEATURES, TREATMENT AND PROGNOSIS OF 94 PATIENTS, European journal of cancer, 34(3), 1998, pp. 329-336
ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES
Authors: MEURMAN JH PYRHONEN S TEERENHOVI L LINDQVIST C
Citation: Jh. Meurman et al., ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES, Oral Oncology, 33(6), 1997, pp. 389-397
5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS
Authors: MEURMAN JH LAINE P LINDQVIST C TEERENHOVI L PYRHONEN S
Citation: Jh. Meurman et al., 5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS, Oral Oncology, 33(6), 1997, pp. 439-443
5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS
Authors: MEURMAN JH LAINE P KEINANEN S PYRHONEN S TEERENHOVI L LINDQVIST C
Citation: Jh. Meurman et al., 5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 83(4), 1997, pp. 447-452
PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: OSTERBORG A DYER MJS BUNJES D PANGALIS GA BASTION Y CATOVSKY D MELLSTEDT H RANKIN E TSEKOURAS C PANGALIS GA CAVALLI F SESSA C HUHN D MARCUS R MAUGHAN T POYNTON C NISSEN N CARNEY D BRITTINGER G UPPENKAMP M ELONEN E TEERENHOVI L",ENGERT,"WILLEMZE R KLUINNELEMANS J THOMAS J EPENETOS AA NETHERSELL A DYER M CATOVSKY D DICATO M BASTION Y COIFFIER B RANADA JMF CROWTHER D WOLL P RAEMAKAERS J DEPAUW B DEGOS L",GISSELLBRECHT,"REIFFERS J MELLSTEDT H FASSAS A ANAGNOSTOPOULOS A BUNJES D JAEGER U STAHEL RA
Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574
STAGE-I NON-HODGKINS-LYMPHOMA TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY
Authors: VILLIKKA K MUHONEN T RISTAMAKI R TEERENHOVI L JOENSUU H
Citation: K. Villikka et al., STAGE-I NON-HODGKINS-LYMPHOMA TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY, Acta oncologica, 36(6), 1997, pp. 619-624
A HIGH PRETREATMENT SERUM VASCULAR ENDOTHELIAL GROWTH-FACTOR CONCENTRATION IS ASSOCIATED WITH POOR OUTCOME IN NON-HODGKINS-LYMPHOMA
Authors: SALVEN P TEERENHOVI L JOENSUU H
Citation: P. Salven et al., A HIGH PRETREATMENT SERUM VASCULAR ENDOTHELIAL GROWTH-FACTOR CONCENTRATION IS ASSOCIATED WITH POOR OUTCOME IN NON-HODGKINS-LYMPHOMA, Blood, 90(8), 1997, pp. 3167-3172
ELEVATED SERUM CD44 LEVEL IS ASSOCIATED WITH UNFAVORABLE OUTCOME IN NON-HODGKINS-LYMPHOMA
Authors: RISTAMAKI R JOENSUU H LAPPALAINEN K TEERENHOVI L JALKANEN S
Citation: R. Ristamaki et al., ELEVATED SERUM CD44 LEVEL IS ASSOCIATED WITH UNFAVORABLE OUTCOME IN NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 4039-4045
COMPARISON OF THE EFFICACY AND TOLERANCE OF INTERLEUKIN-3, G-CSF AND GM-CSF FOLLOWING AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY
Authors: BROWN PN HOVGAARD D REMES K HOLM M TEERENHOVI L ELONEN E NISSEN NI
Citation: Pn. Brown et al., COMPARISON OF THE EFFICACY AND TOLERANCE OF INTERLEUKIN-3, G-CSF AND GM-CSF FOLLOWING AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY, Blood, 88(10), 1996, pp. 2264-2264
VINORELBINE AND EPIRUBICIN IN METASTATIC BREAST-CANCER - A DOSE-FINDING STUDY
Authors: BLOMQVIST C HIETANEN P TEERENHOVI L RISSANEN P
Citation: C. Blomqvist et al., VINORELBINE AND EPIRUBICIN IN METASTATIC BREAST-CANCER - A DOSE-FINDING STUDY, European journal of cancer, 31A(13-14), 1995, pp. 2406-2408
CELL LINEAGE INVOLVEMENT OF RECURRENT CHROMOSOMAL-ABNORMALITIES IN HEMATOLOGIC NEOPLASMS
Authors: KNUUTILA S TEERENHOVI L LARRAMENDY ML ELONEN E FRANSSILA KO NYLUND SJ TIMONEN T HEINONEN K MAHLAMAKI E WINQVIST R RUUTU T
Citation: S. Knuutila et al., CELL LINEAGE INVOLVEMENT OF RECURRENT CHROMOSOMAL-ABNORMALITIES IN HEMATOLOGIC NEOPLASMS, Genes, chromosomes & cancer, 10(2), 1994, pp. 95-102
EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW
Authors: MEURMAN JH LAINE P LINDQVIST C PYRHONEN S TEERENHOVI L
Citation: Jh. Meurman et al., EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW, European journal of cancer. Part B, Oral oncology, 30B(3), 1994, pp. 204-208
2 NOVEL HUMAN B-CELL LYMPHOMA LINES OF LYMPHATIC FOLLICLE ORIGIN - CYTOGENETIC, MOLECULAR-GENETIC AND HISTOPATHOLOGICAL CHARACTERIZATION
Authors: KNUUTILA S KLEFSTROM J SZYMANSKA J LAKKALA T PELTOMAKI P ERAY M TEERENHOVI L ELONEN E FRANSSILA KO KAARTINEN M
Citation: S. Knuutila et al., 2 NOVEL HUMAN B-CELL LYMPHOMA LINES OF LYMPHATIC FOLLICLE ORIGIN - CYTOGENETIC, MOLECULAR-GENETIC AND HISTOPATHOLOGICAL CHARACTERIZATION, European journal of haematology, 52(2), 1994, pp. 65-72
EFFECT OF VITAMIN-E AND BETA-CAROTENE ON THE INCIDENCE OF LUNG-CANCERAND OTHER CANCERS IN MALE SMOKERS
Authors: HEINONEN OP HUTTUNEN JK ALBANES D HAAPAKOSKI J PALMGREN J PIETINEN P PIKKARAINEN J RAUTALAHTI M VIRTAMO J EDWARDS BK GREENWALD P HARTMAN AM TAYLOR PR HAUKKA J JARVINEN P MALILA N RAPOLA S JOKINEN P KARJALAINEN J LAURONEN J MUTIKAINEN J SARJAKOSKI M SUORSA A TIAINEN M VERKASALO M BARRETT M ALFTHAN G EHNHOLM C GREF CG SUNDVALL J HAAPA E OVASKAINEN ML PALVAALHOLA M ROOS E PUKKALA E TEPPO L FRICK H PASTERNACK A BROWN BW DEMETS DL KOKKOLA K TALA E AALTO E MAENPAA V TIENHAARA L JARVINEN M KUULIALA I LINKO L MIKKOLA E NYRHINEN J RONKANEN A VUORELA A KOSKINEN S LOHELA P VILJANEN T GODENHJELM K KALLIO T KASKINEN M HAVU M KIRVES P TAUBERT K ALKIO H KOSKINEN R LAINE K MAKITALO K RASTAS S TANI P NIEMISTO M SELLERGREN TL AIKAS C PEKKANEN PS TARVALA R ALANKO K MAKIPAJA K VAARA S SIUKO H TUOMINEN V ALAKETOLA L HAAPANEN A HAVERI M KESKINISULA L KOKKO E KOSKENKARI M LINDEN P NURMENNIEMI A RANINEN R RAUDASKOSKI T TOIVAKKA SK VIEROLA H KYRONPALOKAUPPINEN S SCHOULTZ E JAAKKOLA M LEHTINEN E RAUTASEPPA K SAARIKOSKI M LIIPPO K REUNANEN K SALOMAA ER ETTINGER D HIETANEN P MAENPAA H TEERENHOVI L PROUT G TASKINEN E ASKIN F EROZAN Y NORDLING S VIROLAINEN M KOSS L SIPPONEN P LEWIN K FRANSSILA K KARKKAINEN P HEINONEN M HYVONEN L KOIVISTOINEN P OLLILAINEN V PIIRONEN V VARO P BILHUBER W SALKELD R SCHALCH W SPEISER R
Citation: Op. Heinonen et al., EFFECT OF VITAMIN-E AND BETA-CAROTENE ON THE INCIDENCE OF LUNG-CANCERAND OTHER CANCERS IN MALE SMOKERS, The New England journal of medicine, 330(15), 1994, pp. 1029-1035
5-HT(3) RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OF ACUTE VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - A RANDOMIZED STUDY
Authors: JANTUNEN IT MUHONEN TT KATAJA VV FLANDER MK TEERENHOVI L
Citation: It. Jantunen et al., 5-HT(3) RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OF ACUTE VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - A RANDOMIZED STUDY, European journal of cancer, 29A(12), 1993, pp. 1669-1672
PRIMARY GASTROINTESTINAL LYMPHOMAS
Authors: TEERENHOVI L
Citation: L. Teerenhovi, PRIMARY GASTROINTESTINAL LYMPHOMAS, Annales chirurgiae et gynaecologiae, 82(1), 1993, pp. 3-4
ONE-YEAR TRIAL OF THE EFFECT OF RINSING WITH AN AMINE FLUORIDE-STANNOUS-FLUORIDE-CONTAINING MOUTHWASH ON GINGIVAL INDEX SCORES AND SALIVARYMICROBIAL COUNTS IN LYMPHOMA PATIENTS RECEIVING CYTOSTATIC DRUGS
Authors: LAINE P MEURMAN JH MURTOMAA H LINDQVIST C TORKKO H PYRHONEN S TEERENHOVI L
Citation: P. Laine et al., ONE-YEAR TRIAL OF THE EFFECT OF RINSING WITH AN AMINE FLUORIDE-STANNOUS-FLUORIDE-CONTAINING MOUTHWASH ON GINGIVAL INDEX SCORES AND SALIVARYMICROBIAL COUNTS IN LYMPHOMA PATIENTS RECEIVING CYTOSTATIC DRUGS, Journal of clinical periodontology, 20(9), 1993, pp. 628-634
COMPARISON OF ONDANSETRON WITH CUSTOMARY TREATMENT IN THE PROPHYLAXISOF NAUSEA AND EMESIS INDUCED BY NON-CISPLATIN CONTAINING CHEMOTHERAPY
Authors: JANTUNEN IT FLANDER MK HEIKKINEN MI KUOPPALA TA TEERENHOVI L KATAJA VV
Citation: It. Jantunen et al., COMPARISON OF ONDANSETRON WITH CUSTOMARY TREATMENT IN THE PROPHYLAXISOF NAUSEA AND EMESIS INDUCED BY NON-CISPLATIN CONTAINING CHEMOTHERAPY, Acta oncologica, 32(4), 1993, pp. 413-415
Risultati: 1-20 |